雌激素对人乳头状瘤病毒16型E6基因转染人永生化表皮细胞效率的影响

摘要
图/表
参考文献
相关文章 (5)

全文: PDF (1323 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：探讨雌激素对人乳头状瘤病毒16（HPV 16）型E6基因转染人永生化表皮细胞效率的影响。方法：以不同浓度的17-β-雌二醇（E2）处理人永生化表皮细胞系（HaCat）后，绘制其生长曲线，以细胞活性测定法（MTT）测定细胞活性，流式细胞仪检测细胞周期分布，溴脱氧尿嘧啶核苷法（BrdU）测定细胞周期时相。脂质体转染法将含HPV 16 E6基因的质粒转染入经不同药物处理后的细胞中，以Real-time PCR法测定细胞中该基因的表达。结果：浓度为10-7～10-5 mol/L的E2促进细胞数目的增加（P＜0.05）；浓度为10-8～10-6 mol/L的E2明显增强细胞活性（P＜0.05）；浓度为10-7～10-5 mol/L的E2使HaCat细胞的细胞周期时相缩短（P＜0.05）；不同浓度E2处理组细胞周期的分布差异无统计学意义（P＞0.05）。当HaCat细胞被HPV 16 E6质粒转染，随着E2浓度的增加，HPV 16 E6 mRNA表达明显增加（P＜0.05）。结论：E2可加速HaCat细胞生长与增殖，增加HPV 16 E6转染HaCat细胞的效率，E2水平升高可能增加HPV感染的风险。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	卢晓声
	陈菁
	赵军招
	吕杰强

关键词 ：人乳头状瘤病毒16型, E6基因, 17-&beta, -雌二醇, 雌激素受体, HaCat细胞

Abstract：Objective: To determine the influence of 17-β-estradiol (E2) on human papilloma virus 16 E6 gene transfecting HaCat cell line and the possible mechanism. Methods: The HaCat cell line was incubated with E2 of varies concentration (10-5, 10-6, 10-7, 10-8, 10-9, 0 mol/L) .The cell number was counted for 7 days to draw a growth curve. The cell viability was determined by MTT method. Flow cytometry was used to detect cell cycle distribution and BrdU to determine the time duration of each cell cycle phase. Then, the E2 treated cells was transfected by the plasmid containing HPV E6. The expression of E6 mRNA was determined by quantitative realtime-PCR. Results: Compared with the control, at the concentration between 10-7-10-5 mol/L, E2 was observed to increase the number of HaCat cells, reduce the doubling time of cell number and increase the cell viability and E6 mRNA expression after transfection (P<0.05). Conclusion: E2 increased the cell growth and viability, enhanced the transfection efficiency of E6 on HaCat cells. The mechanism may be related to the acceleration of cell growth and cell viability.

Key words： human papilloma virus 16 E6 gene 17-β-estradiol estrogen receptor HaCat cell line

收稿日期: 2017-11-02

基金资助:温州市科技计划项目（Y20130191）。

通讯作者: 吕杰强，主任医师，博士生导师，Email：jieqianglu@ 126.com。

作者简介: 卢晓声（1982-），女，浙江温州人，主治医师，博士。

链接本文:

https://xb.wmu.edu.cn/CN/ 或 https://xb.wmu.edu.cn/CN/Y2018/V48/I4/280

[1] GOODMAN A. HPV testing as a screen for cervical cancer [J]. BMJ, 2015, 350: h2372.
[2] 侯柏龙, 杜王琪, 熊一融, 等. 人宫颈癌SiHa细胞荷瘤裸鼠模型的建立及鉴定[J]. 温州医科大学学报, 2016, 46(2): 92-96.
[3] RINALDI S. PLUMMER M, BIESSY C, et al. Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study[J]. Cancer Epidemiol Biomarkers Prev, 2011, 20 (12): 2532-2540.
[4] LUHN P, WALKER J, SCHIFFMAN M, et al. The role of co-factors in the progression from human papillomavirus infection to cervical cancer[J]. Gynecol Oncol, 2013, 128(2): 265-270. [5] SALAZAR E L, GONZALEZ J L, OLMOS A, et al. Influence of the use of oral contraceptives as risk factors for human papillomavirus infection and cervical intraepithelial neoplasia[J]. Ginecol Obstet Mex, 2005, 73(2): 83-89.
[6] ROURA E, TRAVIER N, WATERBOER T, et al. The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort[J]. PLoS One, 2016, 11(1): e0147029.
[7] VACCARELLA S, HERRERO R, DAI M, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys[J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(11): 2148-2153.
[8] LONGATTO-FILHO A, HAMMES L S, SARIAN L O, et al.
Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN[J]. Gynecol Obstet Invest, 2011, 71(2): 93-103.
[9] GAVRIC-LOVREC V, TAKAC I. Use of various contraceptives and human papillomavirus 16 and 18 infections in women with cervical intraepithelial neoplasia[J]. Int J STD AIDS, 2010, 21(6): 424-427.
[10] SON J, PARK J W, LAMBERT P F, et al. Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice[J]. Carcinogenesis, 2013, 35(2): 489-496.
[11] GARCIA C, HERNANDEZ-GARCIA D, VALENCIA C,
et al. E6/E7 oncogenes in epithelial suprabasal layers and estradiol promote cervical growth and ear regeneration[J]. Oncogenesis, 2017, 6(8): e374.
[12] CHUNG S H, SHIN M K, KORACH K S, et al. Requirement for stromal estrogen receptor alpha in cervical neopla-sia[J]. Horm Cancer, 2013, 4(1): 50-59.
[13] MARTINEZ-ZAPIEN D, RUIZ F X, POIRSON J, et al. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53[J]. Nature, 2016, 529(7587): 541-545.
[14] INOUE K, FRY E A. Aberrant expression of Cyclin D1 in cancer[J]. Sign Transduct Insights, 2015, 4: 1-13.
[15] AHLIN C, LUNDGREN C, EMBRETSEN-Varro E, et al. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers[J]. Breast Cancer Res Treat, 2017, 164(3): 667-678.
[16] GRIFFIN L M, CICCHINI L, XU T, et al. Human keratinocyte cultures in the investigation of early steps of human papillomavirus infection[J]. Methods Mol Biol, 2014, 1195: 219-238.
[17] PYEON D, PEARCE S M, LANK S M, et al. Establishment of human papillomavirus infection requires cell cycle pro-gression[J]. PLoS Pathog, 2009, 5(2): e1000318.
[18] MORA-GARCIA M L, ÁVILA-IBARRA L R, GARCIA-ROCHA R, et al. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway[J]. Cell Immunol, 2017, 320: 46-55.